News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Penn Engineering’s newly formed ASSET (AI-enabled Systems: Safety, Explainablity and Trustworthiness) Center is part of Penn Engineering’s Innovation in Data Engineering & Science (IDEAS) Initiative.
For the 5th year, PCI partnered with the Penn Wharton Austin Alumni group to host a startup pitch session in conjunction with SXSW Interactive.
PCI, along with Columbia University and the University of British Columbia, recently completed a license agreement with Heirloom Carbon Technologies.
IBA Worldwide, a technology company that develops particle accelerator technology, partnered with a team of faculty from Radiation Oncology at Penn Medicine led by Dr. James Metz.
Jiren’s career spanned over 30 years as an entrepreneur, C-level and Senior Executive and included founding, scaling and supporting technology businesses.
Launched in 2021, Vivodyne’s platform allows fully automated, complex studies at a far larger scale and lower cost than would be possible with manual experimentation.
Several new research studies reported in the New York Times have demonstrated that multiple doses of a COVID vaccine elicit a durable response in most people that protects them from serious illness
Olivia McPherson, Program Manager, JPOD@PHILADELPHIA, shares how the JPOD and Johnson & Johnson's JLABS program helps startups with life science commercialization.
Penn Engineering secured a multi-million-dollar contract with Wellcome Leap under the organization’s $60 million RNA Readiness + Response (R3) program.